Michael W. Wood, Ph.D., an External Collaborations Director in neuroscience at AstraZeneca, coedited Targets and Emerging Therapies for Schizophrenia with Jeffrey S. Albert, a book that was just published by John Wiley & Sons, Inc. Wood has concentrated his research on neuroscience drug discovery, leading research efforts on novel therapeutics targeting schizophrenia.